ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ITCI Intra Cellular Therapies Inc

69.80
-0.54 (-0.77%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Intra Cellular Therapies Inc NASDAQ:ITCI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.54 -0.77% 69.80 64.01 69.80 71.35 68.48 71.07 909,098 23:29:53

Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

26/05/2021 1:00pm

GlobeNewswire Inc.


Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Intra Cellular Therapies Charts.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at two upcoming investor conferences:

Jefferies Virtual Healthcare Conference

Wednesday, June 2 at 11:30 am ET

Goldman Sachs 42nd Annual Global Healthcare Conference

Thursday, June 10 at 1:20 pm ET

The live and archived webcasts can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:

Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Lisa Burnscradinovic@burnsmc.com212-213-0006

Source: Intra-Cellular Therapies Inc.

1 Year Intra Cellular Therapies Chart

1 Year Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart

1 Month Intra Cellular Therapies Chart

Your Recent History

Delayed Upgrade Clock